| |
|
| |
ThromboGenics is a leading biopharmaceutical company focused on the discovery and development of novel therapeutics
for diseases related to... more » |
|
|
|
|
 |
|
| |
ThromboGenics has developed a strong pipeline of products for the treatment of a broad range of conditions related to the vasculature, including visual disorders, ... more » |
|
|
|
|
|
|
| |
December 16, 2009
ThromboGenics completes patient enrolment of second Phase III Trial of Microplasmin... more »
ThromboGenics rondt de rekrutering van patiënten af in tweede Fase III studie met microplasmine... meer »
December 11, 2009
ThromboGenics announces start of Phase II trial of Microplasmin... more »
ThromboGenics kondigt start aan van Fase II studie met Microplasmine... meer »
|
|
|
|
All rights reserved © ThromboGenics 2006